Overview of current and alternative therapies for idiopathic membranous nephropathy.
about
Albumin-based nanoparticles as methylprednisolone carriers for targeted delivery towards the neonatal Fc receptor in glomerular podocytesPrimary Membranous Nephropathy.Effect of mycophenolic acid in experimental, nontransplant glomerular diseases: new mechanisms beyond immune cells.Circulating (CD3(-)CD19(+)CD20(-)IgD(-)CD27(high)CD38(high)) Plasmablasts: A Promising Cellular Biomarker for Immune Activity for Anti-PLA2R1 Related Membranous Nephropathy?The clinicopathological features of patients with membranous nephropathy.Membranous Nephropathy and Anti-Podocytes Antibodies: Implications for the Diagnostic Workup and Disease Management.
P2860
Overview of current and alternative therapies for idiopathic membranous nephropathy.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Overview of current and alternative therapies for idiopathic membranous nephropathy.
@en
type
label
Overview of current and alternative therapies for idiopathic membranous nephropathy.
@en
prefLabel
Overview of current and alternative therapies for idiopathic membranous nephropathy.
@en
P2093
P2860
P356
P1433
P1476
Overview of current and alternative therapies for idiopathic membranous nephropathy.
@en
P2093
Chuck Greenfeld
Gregory J Hughes
Jacqueline T Pham
Tran H Tran
P2860
P304
P356
10.1002/PHAR.1575
P407
P577
2015-04-01T00:00:00Z